HEX
Server: Apache
System: Linux zacp120.webway.host 4.18.0-553.50.1.lve.el8.x86_64 #1 SMP Thu Apr 17 19:10:24 UTC 2025 x86_64
User: govancoz (1003)
PHP: 8.3.26
Disabled: exec,system,passthru,shell_exec,proc_close,proc_open,dl,popen,show_source,posix_kill,posix_mkfifo,posix_getpwuid,posix_setpgid,posix_setsid,posix_setuid,posix_setgid,posix_seteuid,posix_setegid,posix_uname
Upload Files
File: /home/govancoz/mail/new/1757186847.M674156P217425.zacp120.webway.host,S=7879,W=8019
Return-Path: <ralphanton.ledesma@gtec.com.ph>
Delivered-To: govancoz@zacp120.webway.host
Received: from zacp120.webway.host
	by zacp120.webway.host with LMTP
	id QKn/JR+LvGhRUQMA8rC0kQ
	(envelope-from <ralphanton.ledesma@gtec.com.ph>)
	for <govancoz@zacp120.webway.host>; Sat, 06 Sep 2025 21:27:27 +0200
Return-path: <ralphanton.ledesma@gtec.com.ph>
Envelope-to: cheryl@govan.co.za
Delivery-date: Sat, 06 Sep 2025 21:27:27 +0200
Received: from static.215.193.216.95.clients.your-server.de ([95.216.193.215]:28936 helo=mail.gtec.com.ph)
	by zacp120.webway.host with esmtps  (TLS1.3) tls TLS_AES_256_GCM_SHA384
	(Exim 4.98.2)
	(envelope-from <ralphanton.ledesma@gtec.com.ph>)
	id 1uuyZG-00000000xPP-1nsK
	for cheryl@govan.co.za;
	Sat, 06 Sep 2025 21:27:27 +0200
Comment: DomainKeys? See http://domainkeys.sourceforge.net/
DomainKey-Signature: a=rsa-sha1; q=dns; c=nofws;
  s=default; d=gtec.com.ph;
  b=503/OLD797FsclTrB/GwbXNNfPUvR+yQTMSKGYcx5UYp4f9RwLs+4oWZstYa9wynhkxKzv4L2/F+tyJmLTRQZU7XSx5BczmSoqiedo+ssJHWZ60wZeFR+YFJ5XqfJDIU8qtqfe7/SR20hrC5WsbIFoPzvF8uiSRaih8mmqIRQHG2reVIuwMKC141/7HN2Abe6y6kGZ8Ydo/Bas53KNH6iLM9zBlPNikz8Sihdu8OOAbfDnFKJNI9X1jsYHk4OV87qxaDqLZUc/DLrbgviGj35YocaXruWTxJMl0jhOZuPnAd0P3nSQC2dVwhutE8KieP55GOCRhkoCLJ+LGMjOa1OA==;
  h=Received:Received:Received:Content-Type:MIME-Version:Subject:To:From:Date:Reply-To;
DKIM-Signature: v=1; a=rsa-sha256; c=relaxed; d=gtec.com.ph; h=
	content-type:mime-version:subject:to:from:date:reply-to; s=
	default; bh=NRZ4O7u3fjGlToH9sLN4irGLEoFHP65fcZuzqa2PUEc=; b=M0Aj
	E59cEtr2q3khtIpweyTG3XXP0Dw+JG5YlrLgTLX1Kx4x6S5Wq7EFq6JgRV2v0cfi
	uLMhxmIwhM8m5PA9vGFdI4nVhwQDzRbUZxYgt4Bveie2KDCFNswcloU/qu8X9H9k
	Km3E6rGenV9lLQmXozBXFKBaUK0SkJQyjdZEUfuLB7+ACqoyflxXUExZ5CBy87i9
	7q68RQqt95ihUm/nSjtQrb0sp3y4RlYmTN8i7SSjIz+DVmEg0Sqh1sqDKryoyJtN
	fB62WLv1lPzLlJdw7OAh61NVne8ZjDLfJjYnn6SOGfiuZy7AZ4GCGAdeDEBlnhmD
	sLHW8aH2tvyDf2Ekeg==
Received: (qmail 2011092 invoked by uid 108); 6 Sep 2025 04:41:08 +0800
Received: from unknown (HELO gtec.com.ph) (127.0.0.1)
  by gtec.com.ph with SMTP; 6 Sep 2025 04:41:08 +0800
Received: from ws-dip-gc02.diplomat.com.mt ([212.56.155.179])
	by gtec.com.ph with ESMTPA
	id 8PZ2FeBKu2hpzQYA1q5+Gg
	(envelope-from <ralphanton.ledesma@gtec.com.ph>); Sat, 06 Sep 2025 04:41:04 +0800
Content-Type: multipart/alternative; boundary="===============0393258375=="
MIME-Version: 1.0
Subject: Proposal for Strategic Business Collaboration.
To: Recipients <ralphanton.ledesma@gtec.com.ph>
From: "Dr. Shingo Iwamoto" <ralphanton.ledesma@gtec.com.ph>
Date: Fri, 05 Sep 2025 22:40:54 +0200
Reply-To: drshingoiwamotopharm1@gmail.com
X-Spam-Status: No, score=1.8
X-Spam-Score: 18
X-Spam-Bar: +
X-Ham-Report: Spam detection software, running on the system "zacp120.webway.host",
 has NOT identified this incoming email as spam.  The original
 message has been attached to this so you can view it or label
 similar future email.  If you have any questions, see
 root\@localhost for details.
 Content preview:  Dear Esteemed Professional, I hope this message finds you
   well. Nichi-Iko Pharmaceutical Co., Ltd., a leading pharmaceutical manufacturer
    based in Japan, is currently seeking a qualified individual to [...] 
 Content analysis details:   (1.8 points, 5.0 required)
  pts rule name              description
 ---- ---------------------- --------------------------------------------------
  0.0 RCVD_IN_VALIDITY_SAFE_BLOCKED RBL: ADMINISTRATOR NOTICE: The query to
                              Validity was blocked.  See
                             https://knowledge.validity.com/hc/en-us/articles/20961730681243
                              for more information.
                             [95.216.193.215 listed in sa-accredit.habeas.com]
  0.0 URIBL_BLOCKED          ADMINISTRATOR NOTICE: The query to URIBL was blocked.
                             See
                             http://wiki.apache.org/spamassassin/DnsBlocklists#dnsbl-block
                              for more information.
                             [URI: gtec.com.ph]
 -0.0 SPF_PASS               SPF: sender matches SPF record
  0.1 DKIM_SIGNED            Message has a DKIM or DK signature, not necessarily valid
 -0.1 DKIM_VALID_EF          Message has a valid DKIM or DK signature from
                             envelope-from domain
 -0.1 DKIM_VALID_AU          Message has a valid DKIM or DK signature from author's
                             domain
 -0.1 DKIM_VALID             Message has at least one valid DKIM or DK signature
  0.2 FREEMAIL_REPLYTO_END_DIGIT Reply-To freemail username ends in digit
                             [drshingoiwamotopharm1(at)gmail.com]
  0.0 RCVD_IN_VALIDITY_RPBL_BLOCKED RBL: ADMINISTRATOR NOTICE: The query to
                              Validity was blocked.  See
                             https://knowledge.validity.com/hc/en-us/articles/20961730681243
                              for more information.
                            [95.216.193.215 listed in bl.score.senderscore.com]
  0.0 RCVD_IN_VALIDITY_CERTIFIED_BLOCKED RBL: ADMINISTRATOR NOTICE: The
                             query to Validity was blocked.  See
                             https://knowledge.validity.com/hc/en-us/articles/20961730681243
                              for more information.
                         [95.216.193.215 listed in sa-trusted.bondedsender.org]
  0.0 HTML_MESSAGE           BODY: HTML included in message
  1.8 FREEMAIL_FORGED_REPLYTO Freemail in Reply-To, but not From
X-Spam-Flag: NO

You will not see this in a MIME-aware mail reader.
--===============0393258375==
Content-Type: text/plain; charset="iso-8859-1"
MIME-Version: 1.0
Content-Transfer-Encoding: quoted-printable
Content-Description: Mail message body

Dear Esteemed Professional,
 I hope this message finds you well.
 Nichi-Iko Pharmaceutical Co., Ltd., a leading pharmaceutical manufacturer =
based in Japan, is currently seeking a qualified individual to serve as our=
 official representative in South Africa. This role involves managing miner=
al procurement and overseeing the establishment of our annex office in Sout=
h Africa under a five-year contractual agreement.
 This is a strategic opportunity to represent a respected global brand and =
play a key role in expanding our international presence. We are offering a =
competitive compensation package along with decision-making autonomy.
 If you are interested in learning more, kindly respond to this message for=
 further details.
 Warm regards,
Dr. Shingo Iwamoto
President & CEO
Nichi-Iko Pharmaceutical Co., Ltd.
5-4 Nihonbashi-Honcho 1-chome, Chuo-ku, Tokyo, Japan

--===============0393258375==
Content-Type: text/html; charset="iso-8859-1"
MIME-Version: 1.0
Content-Transfer-Encoding: quoted-printable
Content-Description: Mail message body

<HTML><head><meta http-equiv=3D"Content-Type" content=3D"text/html; charset=
=3Diso-8859-1"/></head><BODY><P>Dear Esteemed Professional,</P>
<P>I hope this message finds you well.</P>
<P>Nichi-Iko Pharmaceutical Co., Ltd., a leading pharmaceutical manufacture=
r based in Japan, is currently seeking a qualified individual to serve as o=
ur official representative in South Africa. This role involves managing min=
eral procurement and overseeing the establishment of our annex office in So=
uth Africa under a five-year contractual agreement.</P>
<P>This is a strategic opportunity to represent a respected global brand an=
d play a key role in expanding our international presence. We are offering =
a competitive compensation package along with decision-making autonomy.</P>
<P>If you are interested in learning more, kindly respond to this message f=
or further details.</P>
<P>Warm regards,<BR>Dr. Shingo Iwamoto<BR>President &amp; CEO<BR>Nichi-Iko =
Pharmaceutical Co., Ltd.<BR>5-4 Nihonbashi-Honcho 1-chome, Chuo-ku, Tokyo, =
Japan</P></BODY></HTML>
--===============0393258375==--